11/10/2025 | Press release | Distributed by Public on 11/10/2025 12:45
|
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | SEC 1473 (7-02) | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | |||
|
1. Title of Derivative Security (Instr. 4) |
2. Date Exercisable and Expiration Date (Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) |
4. Conversion or Exercise Price of Derivative Security |
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) |
6. Nature of Indirect Beneficial Ownership (Instr. 5) |
||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Option (right to buy) | 07/15/2023(2) | 07/15/2029 | Common Stock | 1,745 | $211.59 | D | |
| Option (right to buy) | 08/18/2024(3) | 08/18/2030 | Common Stock | 2,000 | $219.09 | D | |
| Option (right to buy) | 02/08/2022(4) | 02/08/2028 | Common Stock | 1,145 | $181.58 | D | |
| Option (right to buy) | 09/09/2023(5) | 09/09/2029 | Common Stock | 255 | $256.23 | D | |
| Option (right to buy) | 12/15/2019 | 12/15/2025 | Common Stock | 1,200 | $135.53 | D | |
| Option (right to buy) | 10/01/2025(6) | 10/01/2031 | Common Stock | 2,000 | $302.21 | D | |
| Reporting Owner Name / Address | Relationships | |||
| Director | 10% Owner | Officer | Other | |
|
Boyan Barry C. ONE TRIBOLOGY CENTER 102 WILLENBROCK ROAD OXFORD, CT 06478 |
X | |||
| /s/ John J. Feeney/attorney in fact | 11/10/2025 | |
| **Signature of Reporting Person | Date |
| * | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
| ** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| (1) | Includes 2,050 shares of restricted stock that vest according to the following schedule: 224 shares that vest on 2/8/2026; 300 shares 1/2 of which vest on 7/15/2026 and 1/2 vest on 7/15/2027; 100 shares 1/2 of which vest on 9/9/2026 and 1/2 vest on 9/9/2027; 600 shares 1/3 of which vest on 8/18/2026, 1/3 vest on 8/18/2027 and 1/3 vest on 8/18/2028; 696 shares 1/4 of which vest on 10/1/2026, 1/4 vest on 10/1/2027, 1/4 vest on 10/1/2028 and 1/4 vest on 10/1/2029; and 130 shares 1/5 of which vest on 11/20/2025, 1/5 vest on 11/20/2026, 1/5 vest on 11/20/2027, 1/5 vest on 11/20/2028 and 1/5 vest on 11/20/2029. |
| (2) | All these options to purchase Common Stock are exerciseable except for 698 options that vest according to the following schedule: 1/2 vest on 7/15/2026 and 1/2 vest on 7/15/2027. |
| (3) | All these options to purchase Common Stock are exerciseable except for 1,200 options that vest according to the following schedule: 1/3 vest on 8/18/2026, 1/3 vest on 8/18/2027 and 1/3 vest on 8/18/2028. |
| (4) | All these options to purchase Common Stock are exerciseable except for 229 options that vest on 2/8/2026. |
| (5) | All these options to purchase Common Stock are exerciseable except for 102 options that vest according to the following schedule: 1/2 vest on 9/9/2026 and 1/2 vest on 9/9/2027. |
| (6) | All these options to purchase Common Stock are exerciseable except for 1,600 options that vest according to the following schedule: 1/4 vest on 10/1/2026; 1/4 vest on 10/1/2027; 1/4 vest on 10/1/2028 and 1/4 vest on 10/1/2029. |